MENU
Back to Top

Saturday, 15 May 2021 - Program Schedule

*all sessions and times are listed in the Eastern Time Zone (EDT) and subject to change. To assist with how to convert times to your specific time zone; just click here.

08:00 - 09:00

Exhibit Hall Open Visit and meet with exhibitors

09:00 - 09:55

Pregnancy and Vascular Malformations (What Should We Tell the Patient? and How to Prevent Complications)

    Moderators: Leo Schultze Kool (the Netherlands), Steven Fishman (United States)

09:00 - 09:08

Pregnancy and Vascular Malformations: What Changes during Pregnancy Laura Guirado Manchon (Spain)

09:08 - 09:18

AVM’s during Pregnancy Julien Coulie (Belgium)

09:18 - 09:48
 

Case Presentations with Panel Discussion Panelists: Laurence Boon (Belgium), Leonardo Brandão (Canada), Pär Gerwins (Sweden), Gresham Richter (United States), Carine van der Vleuten (the Netherlands), Laura Guirado Manchon (Spain)

 

09:18 - 09:28   Case 1: KTS and Pregnancy Chantal Van der Horst (the Netherlands)

 

09:28  - 09:38  Case 2: Giant Intrahepatic Venous Malformation with Localized Intravascular Coagulopathy. Follow-up and Treatment
                          during Pregnancy.
Annouk Bisdorff-Bresson (France)

 

09:38 - 09:48   Case 3: Large Facial Venous Malformation in a Pregnant Woman Jan Jaap Janssen (the Netherlands)

09:48 - 09:55

Wrap-Up Discussion

09:55 - 10:00

Break

10:00 - 11:25

Hemangiomas and Other Vascular Tumors: Challenging Diagnostic or Management Dilemmas

    Moderators: Francine Blei (United States), Joyce Bischoff (United States)

10:00 - 10:05

IntroductionFrancine Blei (United States)

10:05 - 10:20

Updates from the Ulcerated Hemangioma Multicenter Study Esteban Fernandez-Faith (United States)

10:20 - 10:27

Case 1: Widespread Segmental Infantile Haemangioma with Severe Ulceration Matthew Jones (United Kingdom)

10:27 - 10:42

Basic Science Updates - Propranolol: Mechanism of Action - Some Exciting Insights Caroline Seebauer (Germany)

10:42 - 10:49
 

Case 2: Progressive Infantile Hemangioma Complicated by Poor Response and Poor Tolerance of Beta Blocker Magdalena Soldanska (United States)

10:49 - 11:04

What can we Learn from the PHACE Genetic Registry Dawn Siegel (United States)

11:04 - 11:19

The Hemangioma Referral Score - A Handy Tool Lisa Weibel (Switzerland)

11:19 - 11:25

Discussion

11:25 - 11:30

Break

11:30 - 12:55

Complicated Lymphatic Anomalies (CLA) from Bench to Bedside and Back!

    Moderators: Denise Adams (United States), Gulraiz Chaudry (United States)

11:30 - 11:50

A Clinical overview of Complicated Lymphatic Anomalies: Clinical Pearls of Diagnosis and Treatment Gulraiz Chaudry (United States)

11:50 - 12:35
 

Case Presentations with Panel Discussion Panelists: Juan Carlos Lopez-Gutierrez: (Spain), Jochen Rössler (Switzerland), Maxim Itkin (United States)

 

11:50 - 12:05   Case 1: Generalized Lymphatic Anomaly (GLA) or Gorham Stout Disease (GSD)
                          - Successful Treatment of Chylothorax in Gorham-Stout Disease using Percutaneous Lymphatic Embolization
Michael
                            Fox (United States)

                          - Generalized Lymphatic Anomaly Janna Vassantachart (United States)

 

12:05  - 12:20  Case 2: Kaposiform Lymphangiomatosis (KLA)
                          - Severe KLA Treated with MEK Inhibition
Guy Chowers (Israel)
                          - Chylopericardium Management in CLA Patients Paloma Triana (Spain)

 

12:20 - 12:35   Case 3: Central Conducting Lymphatic Anomaly (CCLA)
                          - Central Conducting Channel Anomaly Presenting with Rectovaginal Leak and Abdominal Pain
Abhay Srinivasan
                            (United States)

                          - Cervicofacial Lymphatic Malformation with Chylothorax Sara Smith (United States)

12:35 - 12:55

Recent Advances in Research on Complicated Lymphatic Anomalies Michael Dellinger (United States)

12:55 - 13:00

Closing Remarks │ Tony Penington (Australia)